News for Ocular Therapeutix, Inc. (0OT.F)

Published at

Mar 5, 2021 2:15 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) ...

RO.SW RHHBF OPNT OCUL FLGT.MX FLGT DMTK.MX DMTK ATRC ACOR A5I.F 7F0.F 7F0.BE 0OT.F 0OT.BE YMTX VYGR.MX VYGR VT6.SG VT6.F VRPX VLON VIVE VIRI V7B1.SG V7B1.F V7B1.BE TLIS TARA SNSE SGTX SANA QURE QLGN ONYN.F ONYN.BE ONCY ONCWF ONCR ONC.TO OLMA NRBO NLSP NEXI NBTX MRNA.MX MRNA LTIA.F LHDX LEGN KRMD KPTI IMRA IKT ICPT.MX ICPT I4P.MU I4P.F I4P.BE GLTO GIS.MU GIS.F GIS.DE GIS.BE GILD.MX GILD.MI GILD GHDN.SG GHDN.MU GHDN.F GHDN.BE EPZM EPE.F EPE.BE DYN DBTX BVS BCTXF BCTX BCT.V BCLI ATNX ASMB APTO APS.TO ALBPS.PA AFIB ADCT 8IY.MU 8IY.F 8IY.BE 8BTA.F 7R9B.MU 7R9B.F 7R9B.BE 6XB.F 2MT.F 25K.SG 25K.MU 25K.F 25K.BE 1KPA.MU 1KPA.F 1KPA.BE 0QF.SG 0QF.MU 0QF.F 0QF.BE TAK FPRX APLS AMGN.BA AMGN AMG.MU AMG.F AMG.DE AMG.BE ABCL 8QQ.HM 8QQ.F 8QQ.BE 1JK.MU 1JK.F 1JK.BE

Read more →
Published at

Feb 23, 2021 2:33 PM

by benzinga.com

mixed

mixed

World Ophthalmic Drugs Market Size, Share & Trends Analysis 2021-2028: Focus on Dry Eye, Eye Allergy, Glaucoma, Eye Infection

Dublin, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The "Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Disease (Dry Eye, Eye Allergy, ...

OYST OCUL NVSN.MX NVSEF NVS NOVN.SW NOTA.MU NOTA.F NOTA.BE JNJD.BA JNJ.SN JNJ.SG JNJ.MX JNJ.MU JNJ.F JNJ.DE JNJ.BE JNJ 0OT.F 0OT.BE RGO.SG RGO.MU RGO.F RGO.BE REGN.MX REGN PFED.BA PFE.SG PFE.MX PFE.MU PFE.F PFE.DE PFE.BE PFE CHRS BAYZF BAYRY BAYNN.MX BAYN.F BAYN.DE BAYN.BE BAYER.BD BAYA.MU BAYA.F BAYA.DE BAYA.BE BAY.MI 8C5.MU 8C5.F

Read more →
Published at

Feb 16, 2021 11:23 PM

by dandodiary.com

mixed

mixed

Guest Post: 2020 Year in Review – Securities Litigation

2020 was an eventful year in the world of corporate and securities litigation. In the following guest post, attorneys from the Haynes and Boone LLP law

WYNN TAX NWL.SG NWL.MU NWL.F NWL DBX.MX DBX ABG.MU ABG.F ABG.BE ABC 1Q5.SG 1Q5.F TGT.MX TGT SYNC RWLK RTPPF RION.MX RIO1.MU RIO1.F RIO1.DE RIO1.BE RIO.L OCUL GS.MX GS GPRO GOS.F GOS.DE GOS.BE DYH.SG DYH.MU DYH.F DYH.DE DYH.BE ALL 5G5.MU 5G5.F 5G5.DE 5G5.BE 2RW.MU 2RW.F 2RW.BE 0OT.F 0OT.BE MWZ.MU MWZ.F MWZ.BE MET.MX MET DHR DAP.MU DAP.F DAP.DE DAP.BE

Read more →
Published at

Feb 15, 2021 9:35 AM

by prnewswire.com

mixed

mixed

Ophthalmic Drug Market Size Worth $60.3 Billion By 2028 | CAGR: 6.4%: Grand View Research, Inc.

/PRNewswire/ -- The global ophthalmic drugs market size is expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc....

OYST OCUL 0OT.F 0OT.BE SZD.F SNPHF NVSN.MX NVSEF NVS NOVN.SW NOTA.MU NOTA.F NOTA.BE CHRS BAYZF BAYRY BAYNN.MX BAYN.F BAYN.DE BAYN.BE BAYER.BD BAYA.MU BAYA.F BAYA.DE BAYA.BE BAY.MI 8C5.MU 8C5.F 4536.T

Read more →
Published at

Feb 12, 2021 10:15 PM

by sec.gov

neutral

neutral

EDGAR Filing Documents for 0001104659-21-021935

Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730 Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235 CIK : 0001393434 (see all company filings) OCU...

OCUL 0OT.F 0OT.BE

Read more →
Published at

Feb 4, 2021 10:01 PM

by thestreet.com

positive

positive

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix, Inc. OCUL, a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases

OCUL 0OT.F 0OT.BE

Read more →
Published at

Jan 20, 2021 2:04 PM

by sec.gov

neutral

neutral

EDGAR Filing Documents for 0001104659-21-005650

Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730 Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235 CIK : 0001393434 (see all company filings) OCU...

OCUL 0OT.F 0OT.BE

Read more →